117
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Anti-ST2 Nanoparticle Alleviates Lung Inflammation by Targeting ILC2s-CD4+T Response

, , , , , , , , , & show all
Pages 9745-9758 | Published online: 03 Dec 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Wells Utembe, Charlene Andraos & Mary Gulumian. (2023) Immunotoxicity of engineered nanomaterials and their role in asthma. Critical Reviews in Toxicology 53:8, pages 491-505.
Read now

Articles from other publishers (5)

Jin Liu, Zeyang Liu, Yan Pang & Huifang Zhou. (2022) The interaction between nanoparticles and immune system: application in the treatment of inflammatory diseases. Journal of Nanobiotechnology 20:1.
Crossref
Xu Zuo, Xiaoping Guo, Yinuo Gu, Haoyu Zheng, Zhengjie Zhou, Xinlei Wang, Shengyu Jiang, Guoqiang Wang, Caina Xu & Fang Wang. (2022) Recent Advances in Nanomaterials for Asthma Treatment. International Journal of Molecular Sciences 23:22, pages 14427.
Crossref
Lan-lan Mi & Wei-wei Guo. (2022) Crosstalk between ILC2s and Th2 CD4+ T Cells in Lung Disease. Journal of Immunology Research 2022, pages 1-12.
Crossref
Aftab Ahmad. (2022) Pharmacological Strategies and Recent Advancement in Nano-Drug Delivery for Targeting Asthma. Life 12:4, pages 596.
Crossref
Bryan J. Mathis, Misa Kusumoto, Alexander Zaboronok & Yuji Hiramatsu. (2021) Packaging and Delivery of Asthma Therapeutics. Pharmaceutics 14:1, pages 92.
Crossref